Rationale for rate-controlled drug delivery of cardiovascular drugs by the transdermal route
- 31 July 1984
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 108 (1) , 196-200
- https://doi.org/10.1016/0002-8703(84)90575-1
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Estrogen replacement therapy by transdermal estradiol administrationAmerican Journal of Obstetrics and Gynecology, 1983
- The evolution of precision drug deliveryCurrent Medical Research and Opinion, 1983
- Rate-controlled drug delivery: pharmacological, therapeutic and industrial perspectivesTrends in Pharmacological Sciences, 1982
- Rate-Controlled Drug DeliveryNew England Journal of Medicine, 1982
- Circadian Changes of Drug Disposition in ManClinical Pharmacokinetics, 1982
- A new model for embryotoxicity testing: teratogenicity and pharmacokinetics of valproic acid following constant-rate administration in the mouse using human therapeutic drug and metabolite concentrationsLife Sciences, 1981
- Nitroglycerin Pharmacokinetics After Intravenous Infusion in Normal SubjectsJournal of Pharmaceutical Sciences, 1981
- Programmed, systemic drug delivery by the transdermal routeTrends in Pharmacological Sciences, 1980